Independent educationNo sales. No dosing. Sources on every brief.
The Peptide Field
Menu

Exact claim · Version 1 · Reviewed 2026-07-23

“TB-500 accelerates tendon and muscle healing in people.”

A verdict on this wording and scope, not a universal grade for TB-500.

01 · Verdict

Not established

The FDA evidence review did not identify adequate human outcome evidence for wound-healing use.

Evidence basis
No reliable human outcome evidence
Scope
Clinical tendon, muscle, and wound-healing outcomes in people.
Category
Performance and recovery

02 · Primary record

Check the attached evidence

01FDA briefing document for TB-500-related bulk drug substancesU.S. Food and Drug Administration · FDA review · 2026
Defines the evidence limit
Editorial review
Internal editorial review recorded
Responsible editor
Anthony Treviso · Founder and responsible editor
Clinical-review boundary
Not independently medically reviewed.